Co-Encapsulation of Fisetin and Cisplatin into Liposomes for Glioma Therapy: From Formulation to Cell Evaluation

(1) Background: Glioblastoma (GBM) is the most frequent cerebral tumor. It almost always relapses and there is no validated treatment for second-line GBM. We proposed the coencapsulation of fisetin and cisplatin into liposomes, aiming to (i) obtain a synergistic effect by combining the anti-angiogen...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Pharmaceutics
Autors principals: Renault-Mahieux, Morgane, Vieillard, Victoire, Seguin, Johanne, Espeau, Philippe, Le, Dang Tri, Lai-Kuen, René, Mignet, Nathalie, Paul, Muriel, Andrieux, Karine
Format: Artigo
Idioma:Inglês
Publicat: MDPI 2021
Matèries:
Article
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC8309049/
https://ncbi.nlm.nih.gov/pubmed/34206986
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/pharmaceutics13070970
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars